Trupanion Inc header image

Trupanion Inc

TRUP

Equity

ISIN US8982021060 / Valor 24738737

NASDAQ (2025-04-08)
USD 32.91-4.47%

Trupanion Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Trupanion Inc is a pet insurance company that was founded in 2000 by Darryl Rawlings, with the aim of providing affordable life-saving coverage for cats and dogs. The company quickly expanded its operations from Canada to the U.S in 2008, and has since grown to insure over 500,000 pets in North America. Trupanion works in partnership with veterinarians to offer a product tailored to the needs of pet owners, with over $1 billion in paid claims on behalf of its members as of 2020.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.01.2025):

Revenue Growth

In the third quarter of 2024, Trupanion Inc. reported a total revenue of $327.5 million, marking a 15% increase compared to the same period in 2023. This growth was primarily driven by the company's subscription business, which saw a significant rise in revenue.

Subscription Business Performance

Trupanion's subscription business revenue reached $219.0 million in Q3 2024, representing a 20% increase from the third quarter of 2023. The number of subscription-enrolled pets also grew by 6%, totaling 1,032,042 as of September 30, 2024.

Net Income Improvement

For the third quarter of 2024, Trupanion Inc. achieved a net income of $1.4 million, or $0.03 per basic and diluted share. This is a notable improvement compared to a net loss of $(4.0) million, or $(0.10) per share, in the third quarter of the previous year.

Cash Flow and EBITDA

Trupanion reported an adjusted EBITDA of $14.5 million for Q3 2024, up from $6.1 million in the same quarter of 2023. The company's operating cash flow was $15.3 million, with a free cash flow of $13.4 million, both showing significant improvements from the previous year.

Financial Position

As of September 30, 2024, Trupanion Inc. held $293.1 million in cash and short-term investments. The company maintained a capital surplus of $274.6 million at its insurance subsidiaries, which was $139.9 million more than the estimated risk-based capital requirement.

Summarized from source with an LLMView Source

Key figures

27.1%1Y
-61.3%3Y
12.8%5Y

Performance

69.8%1Y
80.0%3Y
75.7%5Y

Volatility

Market cap

2106 M

Market cap (USD)

Daily traded volume (Shares)

847,983

Daily traded volume (Shares)

1 day high/low

49.64 / 47.85

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.72%USD 30.77
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.93%USD 19.83
aap Implantate AG
aap Implantate AG aap Implantate AG Valor: 57872565
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.23%EUR 1.65
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.38%USD 12.66
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.65%USD 27.12
Galapagos NV
Galapagos NV Galapagos NV Valor: 3542077
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.08%USD 23.52
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.84%USD 53.07
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 97.91
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.46%USD 66.85
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.96%USD 2.08